---
figid: PMC5409001__dmj-41-89-g002
figlink: /pmc/articles/PMC5409001/figure/F2/
number: F2
caption: . Proposed effect of vasodilatory-stimulated phosphoprotein (VASP) on insulin
  resistance and inflammatory signaling in multiple organs. Nitric oxide (NO)/cyclic
  guanosine monophosphate (cGMP) pathway activates VASP, which inhibits nuclear factor-κB
  (NF-κB) activation; thereby, further inhibiting downstream inflammatory processes
  and enhancing insulin sensitivity. The schematic end-result of NO/cGMP/VASP signaling
  suggests its role against cardiometabolic disorders such as metabolic syndrome,
  type 2 diabetes mellitus, and cardiovascular diseases. Adapted from Cheng et al.
  [], with permission from The American Physiological Society. HF, high-fat; sGC,
  soluble guanylyl cyclase; PDE, phosphodiesterase; PKG, cGMP-dependent protein kinase;
  IRS1, insulin receptor substrate 1; p-AKT, phospho-Akt; p-eNOS, phospho-endothelial
  nitric oxide synthase.
pmcid: PMC5409001
papertitle: Role of NO/VASP Signaling Pathway against Obesity-Related Inflammation
  and Insulin Resistance.
reftext: Yu Mi Kang, et al. Diabetes Metab J. 2017 Apr;41(2):89-95.
pmc_ranked_result_index: '16081'
pathway_score: 0.9605678
filename: dmj-41-89-g002.jpg
figtitle: Role of NO/VASP Signaling Pathway against Obesity-Related Inflammation and
  Insulin Resistance
year: '2017'
organisms: Homo sapiens
ndex: 31e7e1d1-ded2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5409001__dmj-41-89-g002.html
  '@type': Dataset
  description: . Proposed effect of vasodilatory-stimulated phosphoprotein (VASP)
    on insulin resistance and inflammatory signaling in multiple organs. Nitric oxide
    (NO)/cyclic guanosine monophosphate (cGMP) pathway activates VASP, which inhibits
    nuclear factor-κB (NF-κB) activation; thereby, further inhibiting downstream inflammatory
    processes and enhancing insulin sensitivity. The schematic end-result of NO/cGMP/VASP
    signaling suggests its role against cardiometabolic disorders such as metabolic
    syndrome, type 2 diabetes mellitus, and cardiovascular diseases. Adapted from
    Cheng et al. [], with permission from The American Physiological Society. HF,
    high-fat; sGC, soluble guanylyl cyclase; PDE, phosphodiesterase; PKG, cGMP-dependent
    protein kinase; IRS1, insulin receptor substrate 1; p-AKT, phospho-Akt; p-eNOS,
    phospho-endothelial nitric oxide synthase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - PDE3B
  - NFKB1
  - IRS1
  - PDE4B
  - PDE10A
  - AKT2
  - NT5C2
  - PDE8B
  - NOS3
  - PDE4A
  - AKT3
  - SGCB
  - TYR
  - PDE4D
  - PDE4C
  - PDE7B
  - PDE2A
  - PDE3A
  - PDE6A
  - PDE1C
  - PDE6C
  - PDE11A
  - VASP
  - PRKG1
  - PDE1B
  - PDE6B
  - PDE7A
  - PDE1A
  - PDE9A
  - PDE8A
  - Tyr
genes:
- word: p-AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE3B
  entrez: '5140'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: IRS1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4B
  entrez: '5142'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE10A
  entrez: '10846'
- word: p-AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: GMP
  symbol: GMP
  source: hgnc_alias_symbol
  hgnc_symbol: NT5C2
  entrez: '22978'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE8B
  entrez: '8622'
- word: p-ENOS
  symbol: eNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4A
  entrez: '5141'
- word: p-AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: SGC
  symbol: SGC
  source: hgnc_alias_symbol
  hgnc_symbol: SGCB
  entrez: '6443'
- word: Tyr
  symbol: TYR
  source: hgnc_symbol
  hgnc_symbol: TYR
  entrez: '7299'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4D
  entrez: '5144'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4C
  entrez: '5143'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE7B
  entrez: '27115'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE2A
  entrez: '5138'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE3A
  entrez: '5139'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE6A
  entrez: '5145'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE1C
  entrez: '5137'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE6C
  entrez: '5146'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE11A
  entrez: '50940'
- word: VASP
  symbol: VASP
  source: hgnc_symbol
  hgnc_symbol: VASP
  entrez: '7408'
- word: PKG
  symbol: PKG
  source: hgnc_alias_symbol
  hgnc_symbol: PRKG1
  entrez: '5592'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE1B
  entrez: '5153'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE6B
  entrez: '5158'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE7A
  entrez: '5150'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE1A
  entrez: '5136'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE9A
  entrez: '5152'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE8A
  entrez: '5151'
chemicals:
- word: Tyr
  source: MESH
  identifier: D014443
diseases: []
figid_alias: PMC5409001__F2
redirect_from: /figures/PMC5409001__F2
figtype: Figure
---
